Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer. 2019 May 06; 19(1):423.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Cell Cycle
Cell Line, Tumor
Datasets as Topic
Disease Progression
Disease-Free Survival
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Male
Membrane Proteins
Middle Aged
Neoplasm Proteins
Neoplasm Recurrence, Local
Predictive Value of Tests
Prognosis
Prostate
Prostatectomy
Prostatic Neoplasms
Retrospective Studies
RNA, Messenger
Transcriptome
authors with profiles
Adam S Asch
Yan Daniel Zhao
Kar-Ming Fung
Jonathan D. Wren
Maria Jesus Ruiz-Echevarria